Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1
Yunzhou Fan, Guofeng You
Molecular Pharmacology (2020) Vol. 97, Iss. 6, pp. 384-391
Open Access | Times Cited: 16

Showing 16 citing articles:

Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium
Kim L. R. Brouwer, Raymond Evers, Elizabeth R. Hayden, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 3, pp. 461-484
Open Access | Times Cited: 46
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Elena Puris, Gert Fricker, Mikko Gynther
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 364-364
Open Access | Times Cited: 32
Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination
Jinghui Zhang, Haoxun Wang, Yunzhou Fan, et al.
Pharmacology & Therapeutics (2020) Vol. 217, pp. 107647-107647
Open Access | Times Cited: 66
Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion–transporting polypeptides
Wooin Lee, Jeong-Min Ha, Yuichi Sugiyama
Journal of Biological Chemistry (2020) Vol. 295, Iss. 50, pp. 17349-17364
Open Access | Times Cited: 35
Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies
Chao Pan, Leo Tsz On Lee
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189272-189272
Closed Access
Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma
Jiaheng Xie, Zhechen Zhu, Yuan Cao, et al.
Channels (2021) Vol. 15, Iss. 1, pp. 483-495
Open Access | Times Cited: 23
Organic anion transporters in remote sensing and organ crosstalk
Jeffry C. Granados, Sanjay K. Nigám
Pharmacology & Therapeutics (2024), pp. 108723-108723
Open Access | Times Cited: 2
Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma
Rachel L. Mynott, Craig T. Wallington‐Beddoe
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 3, pp. 1050-1065
Open Access | Times Cited: 13
Interaction of two peptide drugs with biomacromolecules analyzed by molecular docking and multi-spectroscopic methods
Linna Fu, Guangbin Liu, Dongxin Zhao, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 255, pp. 119673-119673
Closed Access | Times Cited: 12
Recent Advances on the Regulations of Organic Anion Transporters
Zhou Yu, Guofeng You
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1355-1355
Open Access | Times Cited: 1
Protein kinase C regulates organic anion transporter 1 through phosphorylating ubiquitin ligase Nedd4–2
Zhou Yu, Chenchang Liu, Jinghui Zhang, et al.
BMC Molecular and Cell Biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions
Yunzhou Fan, Zhengxuan Liang, Jinghui Zhang, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 314-314
Open Access | Times Cited: 8
The regulation of human organic anion transporter 4 by insulin-like growth factor 1 and protein kinase B signaling
Zhou Yu, Haoxun Wang, Guofeng You
Biochemical Pharmacology (2023) Vol. 215, pp. 115702-115702
Open Access | Times Cited: 3
Inhibition of proteasome, but not lysosome, upregulates organic anion transporter 3 in vitro and in vivo
Yunzhou Fan, Haoxun Wang, Zhou Yu, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115387-115387
Open Access | Times Cited: 5
Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3
Zhengxuan Liang, Guofeng You
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1725-1725
Open Access | Times Cited: 2
A review of fetal cell lines used during drug development: Focus on COVID-19 vaccines, transplant medications, and biologics
Karin M Durant, Ashlyn Whitesell, Kathy Diener Dasse
American Journal of Health-System Pharmacy (2024) Vol. 81, Iss. 13, pp. e336-e344
Closed Access
Page 1

Scroll to top